Top Markets
Coin of the day
Patient Access Solutions, Inc. Patient Access Solutions, Inc.

Patient Access Solutions, Inc.

PASO
Kedudukan dalam Saham #40839
Patient Access Solutions, Inc. (PASO) specializes in providing comprehensive... Patient Access Solutions, Inc. (PASO) specializes in providing comprehensive financial and administrative processing solutions tailored for the medical and dental sectors. Utilizing its proprietary merchant processing platform, the company facilitates essential services such as patient eligibility verification, streamlined medical billing, and flexible patient self-pay options. Beyond its core payment solutions, PASO offers a range of consultative and operational support, including detailed practice management assistance, strategic business consulting, thorough GAP analyses, and initiatives for marketing and practice development. The firm further diversifies its offerings with therapeutic interventions for conditions like autism, concussion, and PTSD, alongside other biomedical disorders, complemented by a suite of diagnostic testing services. Patient Access Solutions, Inc. is headquartered in Plainview, New York.
Harga Saham
$0.0001
Disegerakkan terakhir: 2026-08-12
Modal Pasaran
$74.06K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Patient Access Solutions, Inc. (PASO)

Kategori

Pendapatan untuk Patient Access Solutions, Inc. (PASO)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Patient Access Solutions, Inc., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Patient Access Solutions, Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$2.04B -
US
$222.34M -
AU
$295.53M -
US
$-259.89M -
US
- -
US